A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...

Heidelberg, Germany — November 14, 2025 — Heidelberg Engineering today announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) ...

Scientists have developed a revolutionary laser treatment to prevent blindness. This non-invasive therapy uses ultra-short ...

Could a new laser treatment prevent blindness from AMD? Learn how this therapy uses gentle heat to activate the eye's repair systems and stop vision loss.

A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...

Age-related macular degeneration (AMD) is a leading cause of blindness in the older population. Geographic atrophy is an advanced stage of dry AMD, characterized by irreversible vision loss due to the ...